162 related articles for article (PubMed ID: 28487941)
21. Identification of key genes and construction of microRNA-mRNA regulatory networks in multiple myeloma by integrated multiple GEO datasets using bioinformatics analysis.
Gao H; Wang H; Yang W
Int J Hematol; 2017 Jul; 106(1):99-107. PubMed ID: 28316065
[TBL] [Abstract][Full Text] [Related]
22. miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8.
Liu T; Meng J; Zhang Y
Mol Med Rep; 2020 Oct; 22(4):3316-3326. PubMed ID: 32945439
[TBL] [Abstract][Full Text] [Related]
23. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
Meng Y; Quan L; Liu A
Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
[TBL] [Abstract][Full Text] [Related]
24. Identification of Skt11-regulated genes in chondrocytes by integrated bioinformatics analysis.
Liang S; Zhang JM; Lv ZT; Cheng P; Zhu WT; Chen AM
Gene; 2018 Nov; 677():340-348. PubMed ID: 30107230
[TBL] [Abstract][Full Text] [Related]
25. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
Zeng JH; Xiong DD; Pang YY; Zhang Y; Tang RX; Luo DZ; Chen G
Oncotarget; 2017 May; 8(22):35681-35699. PubMed ID: 28415685
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
Min XS; Huang P; Liu X; Dong C; Jiang XL; Yuan ZT; Mao LF; Chang S
Tumour Biol; 2015 Sep; 36(10):7457-63. PubMed ID: 25908172
[TBL] [Abstract][Full Text] [Related]
27. Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis.
Wang Z; Gao L; Guo X; Feng C; Deng K; Lian W; Xing B
Oncol Rep; 2019 Aug; 42(2):533-548. PubMed ID: 31173251
[TBL] [Abstract][Full Text] [Related]
28. Identification of potential therapeutic target genes, key miRNAs and mechanisms in oral lichen planus by bioinformatics analysis.
Gong C; Sun S; Liu B; Wang J; Chen X
Arch Oral Biol; 2017 Jun; 78():122-128. PubMed ID: 28237528
[TBL] [Abstract][Full Text] [Related]
29. Identification of genes, pathways and transcription factor-miRNA-target gene networks and experimental verification in venous thromboembolism.
Su Y; Li Q; Zheng Z; Wei X; Hou P
Sci Rep; 2021 Aug; 11(1):16352. PubMed ID: 34381164
[TBL] [Abstract][Full Text] [Related]
30. Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma.
Weng D; He L; Chen X; Lin H; Ji D; Lu S; Ao L; Wang S
Front Immunol; 2022; 13():1055412. PubMed ID: 36713370
[TBL] [Abstract][Full Text] [Related]
31. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
[TBL] [Abstract][Full Text] [Related]
32. Analysis of NFKB2‑mediated regulation of mechanisms underlying the development of Hodgkin's lymphoma.
Zhang Y; Tong L; Chen S; Wu W; Wang L
Mol Med Rep; 2018 Jun; 17(6):8129-8136. PubMed ID: 29693141
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q
Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415
[TBL] [Abstract][Full Text] [Related]
34. Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
Zhan C; Yan L; Wang L; Jiang W; Zhang Y; Xi J; Jin Y; Chen L; Shi Y; Lin Z; Wang Q
Dis Esophagus; 2016 Nov; 29(8):920-928. PubMed ID: 26402921
[TBL] [Abstract][Full Text] [Related]
35. Expression Profiles of Endometrial Carcinoma by Integrative Analysis of TCGA Data.
Sun H; Yan L; Tu R; Zhang Y; Ma L; Tang W; Li L; Chen W; Zhan C; Zang R
Gynecol Obstet Invest; 2017; 82(1):30-38. PubMed ID: 26986489
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives.
Galuppini F; Censi S; Moro M; Carraro S; Sbaraglia M; Iacobone M; Fassan M; Mian C; Pennelli G
Cells; 2021 Apr; 10(4):. PubMed ID: 33924120
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
[TBL] [Abstract][Full Text] [Related]
38. Serum MicroRNA Differences Between Fracture in Postmenopausal Women with and without Diabetes.
Ren C; Li M; Sun L; Li Z; Lu Y; Wang Q; Ma T; Xue HZ; Zhang K
Orthop Surg; 2021 Feb; 13(1):285-295. PubMed ID: 33283469
[TBL] [Abstract][Full Text] [Related]
39. Genes and pathways identified in thyroid carcinoma based on bioinformatics analysis.
Yu JW; Mai W; Cui YL; Kong LY
Neoplasma; 2016; 63(4):559-68. PubMed ID: 27268919
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA network analysis identifies key microRNAs and genes associated with precancerous lesions of gastric cancer.
Wang XW; Wu Y; Wang D; Qin ZF
Genet Mol Res; 2014 Oct; 13(4):8695-703. PubMed ID: 25366760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
